1Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely reseeted non-small-cell lung cancer [ J]. N Engl J Med, 2004, 350:351 - 360.
2Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs observation in resected non-smallcell lung cancer[J]. N Engl J Med, 2005, 352:2589 - 2597.
3Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant chemotherapy in stage I B non-small cell lung cancer(NSCLC) : Update of Cancer and Leukemia Group B (CALGB) protocol 9633 [J]. J Clin Oncol, 2006, 24: a7007.
4Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage I B-ⅢA non-small-cell lung cancer(Adjuvant Navelbine International Trialist Association [ ANITA ] ) : a randomised controlled trial [ J]. Lancet Oncol, 2006,7 (9) :719 - 727.
5Hanna NH, Neubauer M, Ansari R, et al. Phase Ⅲ trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage Ⅲ non-small cell lung cancer ( NSCLC ) : HOG LUN 01-24/USO-023 [ J ]. J Clin Oncol, 2007, 25(18 Suppl) : a7512.
6Mina LA, Neubauer MA, Ansari RH, et al. Phase Ⅲ trial of cisplatin(P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage Ⅲ non-small cell lung cancer ( NSCLC ) : HOG LUN 01-24/USO-023-Updated results [ J ]. J Clin Oncol, 2008, 26(Suppl) : a7519.
7Sandler AB, Gray R, Brahmer J, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer[ J]. New England Journal of Medicine, 2006, 355:2542 -2550.
8Pirker R, Szczesna A, Von Pawel J, et al. FLEX: A randomized, multicenter, phase Ⅲ study of cetuximab in combination with cisplatin/vinorelbine(CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) [J]. J Clin Oneol, 2O08, 26(Suppl) : a3.
9Scagliotti GV, Parikh P, yon Pawel J, et al. Phase Ⅲ study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer [ J ]. J Clin Oncol, 2008, 26 ( 21 ) : 3543 -3551.
10Miller VA, Riely GJ, Zakowski MF, et al. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib [ J ]. J Clin Oncol, 2008, 26 : 1472 - 1478.
2Hughe WT, Armst tong D ,Bodey GP ,et al. 2002 Guidelines for the use of antimicrobial agents in neut ropenic patients with cancer[J] . Clinlnfect Dis,2002,34 (4) :730-751.
